Headlands Technologies »

Janux Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2025-12-31 $780k 57k 13.80

More positions owned by Headlands Technologies

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Booking Holdings (BKNG)
Electronic Arts (EA)
Bank of America Corporation (BAC)
Metropcs Communications (TMUS)
Exxon Mobil Corporation (XOM)
Roper Industries (ROP)
Nasdaq Omx (NDAQ)
Ross Stores (ROST)

View all positions for Headlands Technologies

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
State Street Corporation
Vanguard Group
Adage Capital Partners GP
Prosight Management
OrbiMed Advisors
TCG Crossover Management
Alyeska Investment Group
Geode Capital Management
Goldman Sachs Group
Woodline Partners
Logos Global Management

View all funds holding Janux Therapeutics